PRAX
Praxis Precision Medicines Inc
280.10$
-1.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +14.3% | -40.1% | +10.0% | -16.3% | -17.2% | -15.4% | +2,371.2% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +54.9% | +58.6% | +11.3% | +9,252.0% | -94.3% | +919.0% | -8.9% | -8.0% | +0.4% | -32.6% | +6.5% | +46.7% | +1.0% | +53.6% | +34.4% | +8.0% | +3.6% | +4.4% | +17.8% | -99.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +28.8% | -39.0% | +20.5% | +31.8% | +41.3% | +27.3% | +10.2% | +43.2% | +29.1% | +31.3% | +21.0% | -17.2% | -30.2% | -6.9% | -10.0% | +0.4% | -32.6% | +6.5% | +46.7% | +1.0% | +53.6% | +34.4% | +8.0% | +3.6% | +4.4% | +17.8% | +0.6% | -11.0% | – | |
| – | +0.0% | -16.4% | +37.2% | -10.8% | +57.4% | +36.2% | +175.1% | +0.5% | +13.9% | +7.7% | +30.2% | +6.9% | +1.1% | -15.4% | -8.1% | +4.3% | -23.7% | -13.9% | +13.9% | +54.4% | -31.0% | +44.1% | -0.8% | -8.0% | -6.2% | -3.8% | +55.5% | +42.7% | -1.4% | – | |
| – | +0.0% | +20.8% | -29.7% | +13.0% | +36.6% | +40.2% | +58.5% | +6.6% | +33.1% | +22.7% | +31.0% | -72.4% | +254.4% | -75.9% | -0.9% | -3.3% | -23.7% | -13.9% | +13.9% | +54.4% | -31.0% | +44.1% | -0.8% | -8.0% | -6.2% | -3.8% | +55.5% | +441.8% | -8.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +51.5% | +72.5% | -69.6% | +1.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -103.8% | – | – | – | +131,333.3% | -99.8% | -2,387.5% | – | – | -200.0% | – | – | – | – | – | – | – | – | -115.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.